Comparison |
Alternate Manufacturer Number |
3901006 | 1327261 | 1281526 | 2004877 | 3409893 |
Container Type |
Bottle | Single-Dose Vial | Pharmacy Bulk Vial | Single-Dose Vial | Single-Dose Vial |
Dosage Form |
Capsule | Injection | Injection | Injection | Injection |
Generic Drug Code |
35317 | 97455 | 97457 | 18936 | 38610 |
Generic Drug Name |
Cyclophosphamide | Fluorouracil | Fluorouracil | Methotrexate Sodium, Preservative Free | |
NDC Number |
54879002101 | 63323011710 | 63323011751 | 00703367501 | 16714088601 |
Product Dating |
| McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Quantity |
100 Capsules | | | | |
Storage Requirements |
| | | | Requires Refrigeration |
Strength |
25 mg | 50 mg / mL | 50 mg / mL | 25 mg / mL | 15 Units |
Type |
| Intravenous | Intravenous | | |
UNSPSC Code |
51112507 | 51442004 | 51442004 | 51202203 | 51111733 |
Volume |
| 10 mL | 50 mL | 10 mL | |
Application |
Antineoplastic Agent | Antineoplastic Agent | Antineoplastic Agent | Antineoplastic Agent | Antineoplastic Agent |
Country of Origin |
Unknown | Unknown | Unknown | Unknown | Unknown |
Features and Benefits |
- WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
|
|
|
- Methotrexate injection (preservative free) injectable products may be given by the intramuscular, intravenous, intra-arterial or intrathecal route
|
|